Markus Puhlmann - 20 Jun 2024 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CATX	Stock option (right to buy)	Award	$0	+150,000		$0.000000	150,000	20 Jun 2024	Common Stock	150,000	$10.65	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (06/20/2024), subject to a continued service relationship.